Literature DB >> 15466342

The use of hydrocoil for parent artery occlusion.

David F Kallmes1, Harry J Cloft.   

Abstract

The HydroCoil Embolic System (HES) comprises a platinum microcoil coated with an expansile polymer and is approved by the United States Food and Drug Administration for cerebral aneurysm occlusion. We report a series of five cases, two in the internal carotid artery and three in the vertebral artery, in which the HES was used for parent artery occlusion procedures. In each of these cases, the HES allowed rapid, short-segment occlusion.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15466342      PMCID： PMC7975454     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  6 in total

1.  Coil embolization for the treatment of ruptured dissecting vertebral aneurysms.

Authors:  A Kurata; T Ohmomo; Y Miyasaka; K Fujii; S Kan; T Kitahara
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

2.  New expandable hydrogel-platinum coil hybrid device for aneurysm embolization.

Authors:  David F Kallmes; Naomi H Fujiwara
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

3.  Use of detachable balloons for proximal artery occlusion in the treatment of unclippable cerebral aneurysms.

Authors:  A J Fox; F Viñuela; D M Pelz; S J Peerless; G G Ferguson; C G Drake; G Debrun
Journal:  J Neurosurg       Date:  1987-01       Impact factor: 5.115

4.  Aneurysm packing with HydroCoil Embolic System versus platinum coils: initial clinical experience.

Authors:  Harry J Cloft; David F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

5.  Giant unclippable aneurysms: treatment with detachable balloons.

Authors:  G Debrun; A Fox; C Drake; S Peerless; J Girvin; G Ferguson
Journal:  AJNR Am J Neuroradiol       Date:  1981 Mar-Apr       Impact factor: 3.825

6.  Proximal balloon occlusion for dissecting vertebral aneurysms accompanied by subarachnoid hemorrhage.

Authors:  T Tsukahara; H Wada; K Satake; H Yaoita; A Takahashi
Journal:  Neurosurgery       Date:  1995-05       Impact factor: 4.654
  6 in total
  8 in total

1.  The vascular plug: a new device for parent artery occlusion.

Authors:  I B Ross; R Buciuc
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

2.  Endovascular treatment of carotid cavernous sinus fistula: A systematic review.

Authors:  Bora Korkmazer; Burak Kocak; Ercan Tureci; Civan Islak; Naci Kocer; Osman Kizilkilic
Journal:  World J Radiol       Date:  2013-04-28

3.  Transvenous treatment of cranial dural arteriovenous fistulas with hydrogel coated coils.

Authors:  P Klurfan; T Gunnarsson; I Shelef; K G Terbrugge; R A Willinsky
Journal:  Interv Neuroradiol       Date:  2007-01-19       Impact factor: 1.610

4.  The Hydrodynamic Effect of Bare Platinum Coils versus Hydrogel-Coated Platinum Coils.

Authors:  A Sorteberg; S J Bakke
Journal:  Interv Neuroradiol       Date:  2009-01-05       Impact factor: 1.610

5.  Direct ascending pharyngeal artery to jugular vein arteriovenous fistula. A case report.

Authors:  S D Tomsick; T A Tomsick
Journal:  Interv Neuroradiol       Date:  2008-06-30       Impact factor: 1.610

6.  Packing efficacy of hydrocoil embolic system: in vitro study using ruptured aneurysm model.

Authors:  Kyoichi Watanabe; Kenji Sugiu; Koji Tokunaga; Wataru Sasahara; Shigeki Ono; Isao Date
Journal:  Neurosurg Rev       Date:  2007-02-24       Impact factor: 3.042

7.  Closing the gap between coil and balloon in the neurointerventional armamentarium? Initial clinical experience with a nitinol vascular occlusion plug.

Authors:  Jan Gralla; Gerhard Schroth; Ralph Kickuth; Marwan El-Koussy; Dai-Do Do; Caspar Brekenfeld
Journal:  Neuroradiology       Date:  2008-05-28       Impact factor: 2.804

8.  Difficult indirect carotid-cavernous fistulas--alternative techniques to gaining access for treatment.

Authors:  Nabil El-Hindy; George Kalantzis; Tufail Patankar; Ilias Georgalas; Sreedar Jyothi; Tony Goddard; Bernard Chang
Journal:  Clin Interv Aging       Date:  2014-10-06       Impact factor: 4.458
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.